Clinical Trial Update: Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a four-drug combination (capecitabine, cetuximab, oxaliplatin, and bevacizumab) for metastatic or recurrent colorectal cancer that cann…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• ERBITUX (cetuximab)
• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Herbert Hurwitz | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-05-07